About Insightra
Cardiovascular
Solutions

Insightra Cardiovascular Solutions is a Joint Venture between Insightra Medical Inc., a US-based leader in life saving cardiovascular solutions, and Dolphin Life Science, a high-quality-high-capacity medical device manufacturer based in India. This joint venture combines the strengths of both companies to establish a world-class supplier of FDA-registered cardiovascular products.

The partnership aims to address global healthcare challenges by delivering high-quality, reliable, and innovative cardiovascular solutions at competitive costs. By combining cost-efficient production with recognized US regulatory standards, Insightra Cardiovascular Solutions ensures consistent supply, exceptional quality, and enhanced affordability for healthcare providers worldwide.

Strategically positioned for global distribution, the joint venture integrates Dolphin’s scalable manufacturing capabilities with Insightra’s established global infrastructure. This ensures timely delivery and supply chain resilience, even in the face of global disruptions.

Insightra Cardiovascular Solutions also represents a significant step in positioning India as a global hub for medical device manufacturing. With advanced cleanroom facilities, ISO certifications, and compliance with FDA standards, the company demonstrates how collaboration between regions can set new benchmarks in quality, reliability, and efficiency.

Together, we are creating a supply chain model that ensures healthcare providers and patients receive the best-in-class medical devices, whenever and wherever they are needed.

State-of-the-Art
Manufacturing

The manufacturing operations of Insightra Cardiovascular Solutions are centered at the cutting-edge facility of Dolphin Life Science, located in Surat, Gujarat, India. Spanning over 10,000 square meters, this facility is equipped with advanced infrastructure to meet the most stringent global standards for medical device production.

ISO
14664

The facility adheres to rigorous ISO standards for quality management systems
Class
10,000

Class 10,000 and Class 100,000 Cleanrooms
10,000+
Sq. Mtrs.

Spanning over 10,000 square meters

Dolphin’s manufacturing facility is registered with the US FDA, BRAZILIAN ANVISA, and the DRUGS CONTROLLER GENERAL OF INDIA (DCGI), ensuring compliance with local and Cardiovascular Solutions regulations.

Scalable Production Capacity

Our manufacturing facility is designed to support large-scale production, enabling us to manufacture high volumes of cardiovascular devices without compromising quality. This scalability is vital for addressing the growing demand for medical devices worldwide, particularly in emerging markets.